Two Sigma Investments
VTVT icon

Two Sigma Investments’s vTv Therapeutics VTVT Stock Holding History

Two Sigma Investments’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,692
Closed -$337K – 4761
2021
Q2 		$337K Sell
3,692
-5,745
-61% -$582K ﹤0.01% 3422
2021
Q1 		$1.06M Buy
+9,437
New +$927K ﹤0.01% 2255
2020
Q4 		– Sell
-12,562
Closed -$889K – 3806
2020
Q3 		$889K Buy
12,562
+990
+9% +$87K ﹤0.01% 1841
2020
Q2 		$1.04M Buy
11,572
+4,815
+71% +$475K 0.01% 1517
2020
Q1 		$516K Buy
6,757
+4,549
+206% +$437K ﹤0.01% 1905
2019
Q4 		$150K Buy
+2,208
New +$134K ﹤0.01% 3476

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Two Sigma Investments's VTVT Position: Q3 2021 in Review

Two Sigma Investments sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 3,692 shares — an estimated $337K sold.

Two Sigma Investments first reported a position in VTVT in Q4 2019 and held it in 6 quarters. The position peaked at $1.06M in Q1 2021. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

  • Two Sigma Investments reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Investments sold 3,692 vTv Therapeutics shares in Q3 2021, an estimated $337K.
  • Two Sigma Investments first reported a position in vTv Therapeutics in Q4 2019 and held it in 6 quarters.
  • Two Sigma Investments's vTv Therapeutics position peaked at $1.06M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.